# Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients

> **NCT02284464** · PHASE4 · COMPLETED · sponsor: **Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud** · enrollment: 230 (actual)

## Conditions studied

- Other Complication of Kidney Transplant
- Renal Transplant Rejection

## Interventions

- **DRUG:** Prednisone withdrawal
- **DRUG:** Prednisone continuation

## Key facts

- **NCT ID:** NCT02284464
- **Lead sponsor:** Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-07
- **Final completion:** 2019-12
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2020-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284464, "Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02284464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*